Pharmacogenomics—the study of how genes affect a person's response to drugs—is transforming hormone replacement therapy (HRT) for menopausal women. By analyzing a woman's genetic makeup, healthcare providers can predict her response to HRT, including potential side effects, allowing for the customization of treatment plans. This targeted approach can significantly improve the quality of life for women experiencing menopause, tailoring therapy to their specific genetic profiles.
- Log in or register to contribute
Contribute to three or more articles across any domain to qualify for the Contributor badge. Please check back tomorrow for updates on your progress.